Back to mobile site

More on NRIX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.5 Score)
- Holders

Upcoming Events

- Earnings (7/9/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Nurix Therapeutics (NQ:NRIX)
Delayed: 18.65 +1.10 (6.27%)
Prev. Close $17.55  
Open$17.83 
52 Wk High$ 
52 Wk Low$ 
Day High$18.85 
Day Low$17.83 
P/E N/A  
EPS$ 
Volume2,213,958 

Friends, Peers and Foes (?): S1GE34, CRBU, GTBP, LYEL, SLS (more...)

Jun 18, 2026 06:14 AM Nurix (NRIX) PT Raised to $33 at Baird
Jun 15, 2026 09:30 AM Stifel Reiterates Buy Rating on Nurix (NRIX)
Jun 11, 2026 07:07 AM Form 8-K Nurix Therapeutics, Inc. For: Jun 11
Jun 11, 2026 07:01 AM Nurix reports updated trial results for BTK degrader in blood cancers
Jun 11, 2026 07:00 AM Nurix Therapeutics to Report Updated Phase 1a/b Results for BTK Degrader Bexobrutideg, Highlighting Durable Responses in Relapsed/Refractory CLL/SLL and Promising Activity in Earlier Lines of Therapy
Jun 11, 2026 06:42 AM H.C. Wainwright Reiterates Buy Rating on Nurix (NRIX)
Jun 9, 2026 09:30 AM UBS Reiterates Buy Rating on Nurix (NRIX)
Jun 9, 2026 07:06 AM Nurix (NRIX) PT Raised to $32 at Truist Securities
Jun 8, 2026 01:21 PM Nurix (NRIX) PT Raised to $45 at Jefferies
Jun 8, 2026 01:21 PM Nurix (NRIX) PT Raised to $45 at Jefferies
View All Articles

Entities mentioned with NRIX

View All Entities